Emergent decommissioning of HeartMate 3 for life-threatening hemorrhage.

Autor: Du RE; Section of Cardiothoracic Surgery, Department of Surgery, Ochsner Health, New Orleans, LA., Bedi RS; Section of Cardiothoracic Surgery, Department of Surgery, Ochsner Health, New Orleans, LA., Sternbergh WC 3rd; UQ-Ochsner MD Program, The University of Queensland Faculty of Medicine, Ochsner Health, New Orleans, LA.; Section of Vascular and Endovascular Surgery, Department of Surgery, Ochsner Health, New Orleans, LA., Bansal A; Section of Cardiothoracic Surgery, Department of Surgery, Ochsner Health, New Orleans, LA.; UQ-Ochsner MD Program, The University of Queensland Faculty of Medicine, Ochsner Health, New Orleans, LA.
Jazyk: angličtina
Zdroj: Journal of vascular surgery cases and innovative techniques [J Vasc Surg Cases Innov Tech] 2023 Nov 20; Vol. 10 (2), pp. 101370. Date of Electronic Publication: 2023 Nov 20 (Print Publication: 2024).
DOI: 10.1016/j.jvscit.2023.101370
Abstrakt: Left ventricular assist devices are known for the treatment of heart failure. We present a patient who underwent emergent decommissioning of his left ventricular assist device after experiencing life-threatening hemorrhage. In this case, the patient's outflow graft was avulsed from his left subclavian artery. We used a covered stent to first exclude the outflow graft and an Amplatzer II plug (Abbott Cardiovascular) to then occlude the inflow cannula. Accessing the inflow cannula of the left ventricular assist device was challenging. In hindsight, we could have accessed and occluded the outflow graft via the left subclavian artery before deploying the covered stent.
Competing Interests: A.B. has received speaking honoraria from Abbott and Abiomed and serves on the advisor board for Abbott. R.E.D., R.S.B., and W.C.S. have no conflicts of interest.
(© 2023 The Author(s).)
Databáze: MEDLINE